Adam Feuerstein Is A Skeptic Of Stem Cell Therapy – Benzinga
|
Adam Feuerstein Is A Skeptic Of Stem Cell Therapy
Benzinga “I think it's a very difficult area of drug development, it has not shown much promise,” Feuerstein said. The columnist pointed out that another stem cell related company, Athersys, Inc. (NASDAQ: ATHX), was “blowing up” Friday because its stroke study … |
